Skip to main content
University of California San Francisco
UCSF School of Medicine | Department of Pediatrics UCSF Medical Center

Impact of neighborhood archetypes on overall mortality among young patients with acute leukemia in California.

  • Read more about Impact of neighborhood archetypes on overall mortality among young patients with acute leukemia in California.

Historical redlining and survival among children, adolescents, and young adults with cancer diagnosed between 2000-2019 in Seattle and Tacoma, Washington.

  • Read more about Historical redlining and survival among children, adolescents, and young adults with cancer diagnosed between 2000-2019 in Seattle and Tacoma, Washington.

Langerhans cell histiocytosis: NACHO update on progress, chaos, and opportunity on the path to rational cures.

  • Read more about Langerhans cell histiocytosis: NACHO update on progress, chaos, and opportunity on the path to rational cures.

Association of the social disorganization index with time to first septic shock event in children with acute myeloid leukemia.

  • Read more about Association of the social disorganization index with time to first septic shock event in children with acute myeloid leukemia.

Ethnic disparities in childhood leukemia survival by border residence: A Texas population-based analysis.

  • Read more about Ethnic disparities in childhood leukemia survival by border residence: A Texas population-based analysis.

Type I and Ir pleuropulmonary blastoma (PPB): A report from the International PPB/DICER1 Registry.

  • Read more about Type I and Ir pleuropulmonary blastoma (PPB): A report from the International PPB/DICER1 Registry.

Early-phase clinical trial eligibility and response evaluation criteria for refractory, relapsed, or progressive neuroblastoma: A consensus statement from the National Cancer Institute Clinical Trials Planning Meeting.

  • Read more about Early-phase clinical trial eligibility and response evaluation criteria for refractory, relapsed, or progressive neuroblastoma: A consensus statement from the National Cancer Institute Clinical Trials Planning Meeting.

Reply to Are we certain that chlorhexidine gluconate bathing is not beneficial in deducing central line associated blood stream infections among children with cancer or undergoing hematopoietic stem cell transplantation?

  • Read more about Reply to Are we certain that chlorhexidine gluconate bathing is not beneficial in deducing central line associated blood stream infections among children with cancer or undergoing hematopoietic stem cell transplantation?

Chlorhexidine gluconate bathing in children with cancer or those undergoing hematopoietic stem cell transplantation: A double-blinded randomized controlled trial from the Children's Oncology Group.

  • Read more about Chlorhexidine gluconate bathing in children with cancer or those undergoing hematopoietic stem cell transplantation: A double-blinded randomized controlled trial from the Children's Oncology Group.

Stroke impact on mortality and psychologic morbidity within the Childhood Cancer Survivor Study.

  • Read more about Stroke impact on mortality and psychologic morbidity within the Childhood Cancer Survivor Study.

Pagination

  • Page 1
  • Next page ››
Subscribe to Cancer

Pediatrics Home

MAKE A GIFT

© 2022 The Regents of the University of California. The University of California San Francisco  |  UCSF Department of Pediatrics                                                                                              Accessibility  Privacy Policy  Terms of Use  A-Z Website List